Diacurimap Plus is an advanced dual-action medication containing Empagliflozin (25mg) and Linagliptin (5mg). It is designed to improve glycemic control in adults with type 2 diabetes mellitus by utilizing two different mechanisms to lower blood sugar levels effectively.